Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

sodium benzoate

Generic Name: sodium benzoate

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease.

Not Applicable

Completed

Posted: 2019/07/17

Sponsor:Institute of Liver a...

ID:NCT04022941

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

Phase 2

Completed

Posted: 2018/04/27

Sponsor:Pakistan Institute o...

ID:NCT03510741

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Phase 2

Recruiting

Posted: 2017/03/29

Sponsor:SyneuRx Internationa...

ID:NCT03094429

Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults

Phase 2

Terminated

Posted: 2014/10/10

Sponsor:SyneuRx Internationa...

ID:NCT02261519

Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders

Not Applicable

Completed

Posted: 2014/04/11

Sponsor:Baylor College of Me...

ID:NCT02111200

FDA Approved Products

Ammonul

Manufacturer:Ucyclyd Pharma Inc.

Route:INTRAVENOUS

Strength:100 mg in 1 mL

Approved: 2018/01/12

NDC:62592-720

SODIUM PHENYLACETATE and SODIUM BENZOATE

Manufacturer:Woodward Pharma Services LLC

Route:INTRAVENOUS

Strength:100 mg in 1 mL

Approved: 2021/12/15

NDC:69784-811

SODIUM PHENYLACETATE AND SODIUM BENZOATE

Manufacturer:Oceanside Pharmaceuticals

Route:INTRAVENOUS

Strength:100 mg in 1 mL

Approved: 2020/12/01

NDC:68682-001

Sodium phenylacetate and Sodium benzoate

Manufacturer:Zydus Pharmaceuticals USA Inc.

Route:INTRAVENOUS

Strength:100 mg in 1 mL

Approved: 2023/10/30

NDC:70710-1926

Sodium Phenylacetate and Sodium Benzoate

Manufacturer:Mylan Institutional LLC

Route:INTRAVENOUS

Strength:100 mg in 1 mL

Approved: 2021/03/16

NDC:67457-844

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy